rs147900290

Variant names:

• chr19-41352674-G-A
• rs147900290
• NM_000660.7:c.355+16C>T

GermlineCancer (beta)

Variant summary

Our verdict is Uncertain significance.

+1 Uncertain · Cold

-7

-6

-1

0

+5

+6

+9

+10

BenignB

Likely BenignLB

UncertainVUS

Likely PathogenicLP

PathogenicP

The variant received 1 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_Supporting

The NM_000660.7(TGFB1):c.355+16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The gene TGFB1 is a tumor suppressor gene (CancerMine: 2 TSG, 9 oncogene, 5 driver citations). The gene TGFB1 is a known oncogene (CancerMine: 2 TSG, 9 oncogene, 5 driver citations). The gene TGFB1 is a cancer driver gene (CancerMine: 2 TSG, 9 oncogene, 5 driver citations). The variant allele was found at a cumulative frequency of 0.00000993 (AC=16) in the gnomAD database across 1,611,892 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000008. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★).

• Frequency:
  • Genomes: 𝑓 0.000026 (0 hom., cov: 31)
  • Exomes 𝑓: 0.0000082 (0 hom.)
• Consequence: TGFB1 NM_000660.7 intron
• Clinical Significance: Likely benign criteria provided, single submitter B:1
• Conservation: PhyloP100: 1.30
• Publications: 0 publications found

Genes affected

TGFB1 (HGNC:11766): (transforming growth factor beta 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016]

TGFB1 Gene-Disease associations (from GenCC):

• Camurati-Engelmann disease

  Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
• Camurati-Engelmann disease type 1

  Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
• inflammatory bowel disease, immunodeficiency, and encephalopathy

  Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
• cystic fibrosis

  Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

TMEM91 (HGNC:32393): (transmembrane protein 91) Predicted to act upstream of or within hematopoietic progenitor cell differentiation. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Jun 2026]

ENSG00000255730 (HGNC:):

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 1 points.

Apply	Criterion Code & Title / Strength	Strength	Rationale / Clinical Context
	O3Absent or very rare in population		Very rare in gnomAD (popmax AF <0.01%) — O3 supporting; GnomAD effective popmax AF = 0.000008 — very rare (O3 supporting [+1])

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000660.7. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.	Gene / Transcript	Tags	HGVSc / HGVSp	Effect	Exon rank	Protein / UniProt
	TGFB1 NM_000660.7	MANE Select	c.355+16C>T	intron	Intron 1 of 6	Prot: NP_000651.3 UniProt:

TGFB1 NM_000660.7

MANE Select

HGVSc / HGVSpc.355+16C>T

Exon rankIntron 1 of 6

intron

Prot: NP_000651.3UniProt: P01137A0A499FJK2

Ensembl Transcripts

Sel.	Gene / Transcript	Tags	HGVSc / HGVSp	Effect	Exon rank	Protein / UniProt
	TGFB1 ENST00000221930.6	TSL:1MANE Select	c.355+16C>T	intron	Intron 1 of 6	Prot: ENSP00000221930.4 UniProt:
	TMEM91 ENST00000539627.5	TSL:1	c.-30+1472G>A	intron	Intron 1 of 2	Prot: ENSP00000441900.1 UniProt:
	TGFB1 ENST00000890114.1		c.355+16C>T	intron	Intron 1 of 6	Prot: ENSP00000560173.1 UniProt:

TGFB1 ENST00000221930.6

TSL:1MANE Select

HGVSc / HGVSpc.355+16C>T

Exon rankIntron 1 of 6

intron

Prot: ENSP00000221930.4UniProt: A0A499FJK2P01137

TMEM91 ENST00000539627.5

TSL:1

HGVSc / HGVSpc.-30+1472G>A

Exon rankIntron 1 of 2

intron

Prot: ENSP00000441900.1UniProt: F5GWC9

TGFB1 ENST00000890114.1

HGVSc / HGVSpc.355+16C>T

Exon rankIntron 1 of 6

intron

Prot: ENSP00000560173.1UniProt: A0ACI8QUD2

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)

Rare (AF ≤ 0.0001 / Hom ≤ 1)

Source / population	AF	AC	Hom	AN	Coverage
Global population databases 6 sources Large-scale international reference populations
GnomAD3 genomes	AF: 0.0000263	AC:4	Hom:0	AN:152092	Cov:31
GnomAD2 exomes	AF: 0.0000125	AC:3	Hom:	AN:239896	Cov:
GnomAD4 exome	AF: 0.00000822	AC:12	Hom:0	AN:1459800	Cov:32
GnomAD4 genome	AF: 0.0000263	AC:4	Hom:0	AN:152092	Cov:31
TOPMed (Bravo)	AF: 0.0000189	AC:	Hom:	AN:	Cov:
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)	AF: 0.00	AC:0	Hom:0	AN:16840	Cov:

Showing 6 sources

Case/control cohorts

Cohort	Cases			Controls
	AF	AC	AN	AF	AC	AN
SCHEMA(Schizophrenia)	0.0000233	2	85884	0.00	0	138376

Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions

Significance: Likely benign

Revision: criteria provided, single submitter

Pathogenic	VUS	Benign	Condition
-	-	1	not provided (1)

Computational Scores

Algorithm	Calibrated pred.	Score	Prediction
AlphaGenome AVI	Benign	6.5
BayesDel_noAF	Benign	-0.34
CADD	Benign	8.2
DANN	Benign	0.97
GPN-Star LLR	N/A	-2.0
GPN-Star score	N/A	2.0
PhyloP100	Benign	1.3
PromoterAI	N/A	-0.0012	Neutral
RBP_binding_hub_radar	N/A	0.0
RBP_regulation_power_radar	N/A	2.1

Showing 10 of 10 scores

Splicing Scores

Algorithm	Calibrated pred.	Score	Prediction
Pangolin (max)	Benign	0.010
SpliceAI score (max)	Benign	0.010	Details are displayed if max score is > 0.2

Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Other links and lift over

dbSNP: rs147900290;

hg19: chr19-41858579;

ACMG debug oncogenicity

ACGS debug oncogenicity

ACMG debug germline

Submit to ClinVar